Cocrystal Pharma (COCP) Enterprise Value (2010 - 2026)
Cocrystal Pharma (COCP) reported Enterprise Value of -$4.8 million for Q1 2026, up 31.62% on a YoY basis from -$3.7 million in Q1 2025, and up 32.61% sequentially from -$7.2 million in Q4 2025.
Cocrystal Pharma (COCP) Enterprise Value (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 17 years of Enterprise Value data on file, last reported at -$4.8 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 31.62% year-over-year to -$4.8 million; the trailing twelve-month figure through Mar 2026 stood at -$4.8 million (up 31.62% YoY), and the FY2025 full-year result was -$7.2 million, up 28.32% from the prior year.
- Enterprise Value grew to -$4.8 million in Q1 2026, from -$7.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$150000.0 in Q2 2022 to a low of -$54.8 million in Q1 2022.
- A 5-year average of -$16.3 million and a median of -$10.0 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 99.78% in 2022 and plunged 21562.67% in 2023, its largest moves.
- Tracing COCP's Enterprise Value over 5 years: stood at -$37.3 million in 2022, then advanced by 28.93% to -$26.5 million in 2023, then soared by 62.23% to -$10.0 million in 2024, then grew by 28.32% to -$7.2 million in 2025, then jumped by 32.61% to -$4.8 million in 2026.
- Business Quant data shows COCP's Enterprise Value at -$4.8 million in Q1 2026, -$7.2 million in Q4 2025, and -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | -4.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.84 Mn |
| Dec 31, 2025 | -7.18 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | -7.07 Mn |
| Dec 31, 2024 | -10.01 Mn |
| Sep 30, 2024 | -13.17 Mn |
| Jun 30, 2024 | -18.29 Mn |
| Mar 31, 2024 | -21.99 Mn |
| Dec 31, 2023 | -26.50 Mn |
| Sep 30, 2023 | -29.89 Mn |
| Jun 30, 2023 | -32.49 Mn |
| Mar 31, 2023 | -150,000.00 |
| Dec 31, 2022 | -37.29 Mn |
| Sep 30, 2022 | -150,000.00 |
| Jun 30, 2022 | -150,000.00 |
| Mar 31, 2022 | -54.79 Mn |
| Dec 31, 2021 | -58.76 Mn |
| Sep 30, 2021 | -61.58 Mn |
| Jun 30, 2021 | -67.06 Mn |